Compounds having antibacterial activity are disclosed. The compounds have the following structure (I):
including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q
1
, Q
2
, Q
3
, R
1
, R
2
and R
3
are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.